MAT2A-IN-20 (Compound A49) is an inhibitor for methionine adenosyltransferase 2A ( MAT2A ) with an IC 50 ≤50 nM. MAT2A-IN-20 inhibits human UGT1A1 with an IC 50 of 28.45 μM. MAT2A-IN-20 exhibits antitumor in mouse models.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Methionine Adenosyltransferase (MAT)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.